The side effects of birth control include spotting, headaches, missed periods, mood swings, nausea, and more.
Patients often have many questions for Dr. Ashish Premkumar, an OB-GYN who specializes in high-risk pregnancies. But before this week, he wouldn’t have expected the safety of Tylenol to be at the top ...
OLATHE — A trial that could determine whether state-imposed abortion restrictions can remain in Kansas began Friday with testimony from the abortion providers behind the challenge. Traci Lynn Nauser, ...
Minnesota’s strength up the middle has long been tied to its success. As the roster continues to evolve, the team’s future ...
A 2017 tweet from Tylenol reposted by both HHS and the White House is being taken wildly out of context, experts said. On Wednesday morning, the White House shared an X post from Tylenol dated March 7 ...
Tylenol is one of the most common pain relievers recommended to pregnant women, but the White House wants that to change over concerns the drug may be linked to autism. Some experts, though, dispute ...
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each ...
Potassium is vital for health, but it poses risks when kidneys fail. Kidneys filter excess potassium, but kidney disease impairs this function. High potassium is common in chronic kidney disease. It ...
CHICAGO (WLS) -- All outbound lanes are reopening this week, nearing the finish line of the three-year Kennedy Reconstruction Project, according to the Illinois Department of Transportation. IDOT said ...
U.S. private sector businesses lost 32,000 workers in September as growing concerns about the economy kept employers from expanding their payrolls, according to data released Wednesday. The ADP ...
Not all things have to be related to the ice, and the fans who love the dining experience at a game now have more options. FOX31's Greg Nieto was inside Ball Arena to hear from fans. Blast at a ...
Eli Lilly has pulled the plug on a phase 2b obesity trial before enrolling a single patient, citing “strategic business reasons.” The study was designed to test bimagrumab, an asset Lilly acquired in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results